ClassID:

21214

A61K2039/6025 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen Nucleotides

Recent Application in this class:
#1
20260108599
2026-04-23

THERAPEUTIC COMPOUND AND METHOD OF PREPARING A THERAPEUTIC VACCINE FOR THE TREATMENT OF ALLERGIC AND AUTOIMMUNE DISEAES USING IMMUNIZATION WITH ENGINEERED BACTERIAL DNA OR CpG MOTIFS DERIVIDE FROM COMMENSAL BACTERIA SUCH AS Bifidobacterium longun subsp. infantis.

#2
20260077027
2026-03-19

PEPTIDE AND NUCLEIC ACID METHODS TO MODULATE DELIVERY OF NUCLEIC ACID STRUCTURES, POLYPEPTIDES, AND THEIR CARGOES

#3
20260053906
2026-02-26

DNA ORIGAMI VACCINES

#4
20260027198
2026-01-29

VIRUS POLYPEPTIDE-PROTEIN SUBUNIT COMBINATION VACCINE BASED ON DNA NANOTECHNOLOGY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#5
20250387466
2025-12-25

COMPOSITIONS OF NUCLEIC ACID NANOSTRUCTURES FOR VACCINES AND METHODS OF USE THEREOF

#6
20250295745
2025-09-25

CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES

#7
20250009872
2025-01-09

COMPOSITIONS AND METHODS FOR MODULAR VACCINES

#8
20240408194
2024-12-12

DNA ORIGAMI SUBUNIT VACCINE FOR PREVENTION OF SARS-CoV-2 VARIANT INFECTION

#9
20230330219
2023-10-19

NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR PROGRAMMING IMMUNE STIMULATION

#10
20230143135
2023-05-11

COMPOSITION FOR DELIVERY OF A BIOACTIVE AGENT AND METHOD OF MANUFACTURE AND USE THEREOF

#11
20220088163
2022-03-24

Hybrid immolative cell-penetrating complexes for nucleic acid delivery

#12
20210023227
2021-01-28

Methods And Compositions For Templated Assembly Of Nucleic Acid Specific Heterocompounds

#13
20200246455
2020-08-06

Synthetic conjugate of CpG DNA and T-help/CTL peptide

#14
20200237903
2020-07-30

Nucleic acid nanostructure platform for antigen presentation and vaccine formulations formed therefrom

#15
20190390200
2019-12-26

RNA-based compositions and adjuvants for prophylactic and therapeutic treatment

#16
20190160173
2019-05-30

Oligonucleotide constructs and uses thereof

#17
20190054145
2019-02-21

Methods of treating cancer cells expressing tumor-associated integrins

#18
20190022207
2019-01-24

Compositions and Methods for Treating Acne

#19
20180360950
2018-12-20

Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof

#20
20180243409
2018-08-30

Synthetic conjugate of CpG DNA and T-help/CTL peptide

#21
20170273905
2017-09-28

Lipid membrane structure for intracellular delivery of siRNA

#22
20170175122
2017-06-22

RNA-based compositions and adjuvants for prophylactic and therapeutic treatment

#23
20170007695
2017-01-12

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

#24
20170002355
2017-01-05

cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY

#25
20160271268
2016-09-22

NUCLEIC ACID NANOSTRUCTURES FOR IN VIVO AGENT DELIVERY

#26
20160106854
2016-04-21

Methods and compositions for templated assembly of nucleic acid specific heterocompounds

#27
20160000906
2016-01-07

Synthetic conjugate of CpG DNA and T-help/CTL peptide

#28
20150320883
2015-11-12

Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals

#29
20150301058
2015-10-22

BIOMARKER COMPOSITIONS AND METHODS

#30
20150191730
2015-07-09

Aptamer-targetted antigen delivery

#31
20150110831
2015-04-23

Compositions and methods

#32
20120301466
2012-11-29

CHEMICALLY PROGRAMMABLE IMMUNITY

#33
20120276136
2012-11-01

Chemically programmable immunity

#34
20110300223
2011-12-08

Immunogenic composition

#35
20110293565
2011-12-01

NOVEL SYNTHETIC AGONISTS OF TLR9

#36
20110189180
2011-08-04

Antigenic compositions and use of same in the targeted delivery of nucleic acids

#37
20110123561
2011-05-26

METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE

#38
20100285050
2010-11-11

Compositions and Methods

#39
20100247535
2010-09-30

Chemically programmable immunity

#40
20090196915
2009-08-06

COMPOSITION AND METHODS OF MAKING AND USING INFLUENZA PROTEINS

#41
20090148479
2009-06-11

Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein

#42
20090142368
2009-06-04

Chemically programmable immunity

#43
20080226667
2008-09-18

Innate immune system-directed vaccines

#44
20080113929
2008-05-15

Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist

#45
20080050397
2008-02-28

Multiple antigenic agents and methods for using the same

#46
20080031887
2008-02-07

Conjugates for inducing targeted immune responses and methods of making and using same

#47
20070212337
2007-09-13

Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders

#48
20070190073
2007-08-16

Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof

#49
20070160623
2007-07-12

Innate immune system-directed vaccines

#50
20070148183
2007-06-28

Chemically programmable immunity

#51
20070122421
2007-05-31

Innate immune system-directed vaccines

#52
20070036807
2007-02-15

Compositions comprising structurally stable conjugate molecules

#53
20060193869
2006-08-31

Methods and compositions for induction or promotion of immune tolerance

#54
20060171961
2006-08-03

Composition and method for preventing or treating a virus infection

#55
20050158336
2005-07-21

Synthetic conjugate of CpG DNA and T-help/CTL peptide